Table 1.
Amyloid | Tau | |||
---|---|---|---|---|
| ||||
CN (N=196) | Full (N=216) | CN (N=95) | Full (N=103) | |
Age, years | 77.74 (8.56) | 78.55 (8.72) | 76.04 (8.59) | 76.85 (8.89) |
Female | 101 (51.5%) | 107 (49.5%) | 55 (57.9%) | 58 (56.3%) |
Black | 35 (17.9%) | 38 (17.6%) | 17 (17.9%) | 19 (18.4%) |
Other | 10 (5.1%) | 10 (4.6%) | 6 (6.3%) | 6 (5.9%) |
White | 151 (77.0%) | 168 (77.8%) | 72 (75.8%) | 78 (75.7%) |
Education, years | 17.18 (2.39) | 17.24 (2.43) | 17.66 (2.43) | 17.60 (2.51) |
Diagnosis: MCI^ | 0 (0%) | 13 (6%) | 0 (0%) | 6 (5.8%) |
Diagnosis: Dementia^ | 0 (0%) | 5 (2.3%) | 0 (0%) | 0 (0%) |
APOE e4 carrier | 56 (28.9%) | 63 (29.6%) | 26 (28.0%) | 29 (29.0%) |
Hippocampus (cm3) | 7.29 (0.76) | 7.25 (0.80) | 7.34 (0.76) | 7.29 (0.77) |
CESD ≥ 16 | 12 (6.1%) | 16 (7.4%) | 5 (5.3%) | 6 (5.8%) |
Amyloid PiB+ | 57 (29.1%) | 72 (33.3%) | 21 (22.1%) | 26 (25.2%) |
Amyloid mean cortical | 1.09 (0.18) | 1.11 (0.18) | 1.07 (0.15) | 1.11 (0.18) |
Amyloid Precuneus | 1.17 (0.23) | 1.19 (0.24) | 1.15 (0.19) | 1.19 (0.24) |
Tau Entorhinal | 1.03 (0.17) | 1.04 (0.18) | 1.03 (0.17) | 1.04 (0.18) |
Tau Fusiform | 1.16 (0.22) | 1.16 (0.21) | 1.16 (0.22) | 1.16 (0.21) |
Tau Inferior temporal gyrus | 1.30 (0.21) | 1.31 (0.20) | 1.30 (0.21) | 1.31 (0.20) |
Tau Hippocampus | 1.31 (0.27) | 1.32 (0.29) | 1.31 (0.27) | 1.32 (0.29) |
Neuroticism | 44.37 (8.65) | 44.74 (8.76) | 43.44 (9.19) | 43.76 (9.27) |
Extraversion | 49.59 (10.12) | 49.63 (10.14) | 49.46 (11.79) | 49.43 (11.65) |
Openness | 51.63 (9.93) | 51.07 (9.89) | 52.10 (10.03) | 51.33 (10.16) |
Agreeableness | 54.46 (9.29) | 54.30 (9.18) | 55.19 (10.05) | 55.09 (10.07) |
Conscientiousness | 52.33 (9.87) | 51.87 (10.08) | 54.12 (10.47) | 53.99 (10.49) |
Notes. CN = Cognitively normal. CESD = Center for Epidemiological Studies-Depression. MCI = Mild Cognitive Impairment. PiB = 11C-Pittsburgh compound B. In parenthesis are SD or percentages. Age at the time of personality assessment. APOE data was missing for 3 individuals. PiB statistics are distribution volume ratio (DVR) and tau are standardized uptake value ratio (SUVR).
The difference between CN and Full sample includes impaired participants, of whom two had impairment other than MCI or dementia.